Janus Henderson Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.91M Buy
7,900
+6,696
+556% +$1.62M ﹤0.01% 1306
2025
Q1
$293K Hold
1,204
﹤0.01% 2211
2024
Q4
$396K Hold
1,204
﹤0.01% 2147
2024
Q3
$403K Sell
1,204
-1,443
-55% -$483K ﹤0.01% 2135
2024
Q2
$723K Sell
2,647
-109
-4% -$29.8K ﹤0.01% 1797
2024
Q1
$952K Buy
2,756
+3
+0.1% +$1.04K ﹤0.01% 1670
2023
Q4
$890K Sell
2,753
-16
-0.6% -$5.17K ﹤0.01% 1684
2023
Q3
$993K Sell
2,769
-143
-5% -$51.3K ﹤0.01% 1560
2023
Q2
$1.1M Sell
2,912
-255
-8% -$96.6K ﹤0.01% 1560
2023
Q1
$1.52M Sell
3,167
-14,925
-82% -$7.15M ﹤0.01% 1413
2022
Q4
$7.61M Sell
18,092
-8,248
-31% -$3.47M 0.01% 775
2022
Q3
$11M Buy
26,340
+14,208
+117% +$5.93M ﹤0.01% 805
2022
Q2
$6.01M Sell
12,132
-36,193
-75% -$17.9M ﹤0.01% 803
2022
Q1
$27.2M Sell
48,325
-21,323
-31% -$12M 0.01% 677
2021
Q4
$52.6M Sell
69,648
-55,859
-45% -$42.2M 0.02% 531
2021
Q3
$93.6M Sell
125,507
-24,950
-17% -$18.6M 0.04% 370
2021
Q2
$96.9M Buy
150,457
+58,933
+64% +$38M 0.04% 373
2021
Q1
$52.3M Buy
91,524
+34,635
+61% +$19.8M 0.02% 538
2020
Q4
$33.2M Buy
56,889
+12,587
+28% +$7.34M 0.02% 638
2020
Q3
$22.8M Buy
44,302
+13,023
+42% +$6.71M 0.01% 680
2020
Q2
$14.1M Buy
31,279
+30,599
+4,500% +$13.8M 0.01% 763
2020
Q1
$238K Buy
+680
New +$238K ﹤0.01% 1246
2019
Q2
Sell
-866
Closed -$265K 1373
2019
Q1
$265K Sell
866
-483
-36% -$148K ﹤0.01% 1304
2018
Q4
$313K Buy
+1,349
New +$313K ﹤0.01% 1268
2018
Q3
Sell
-3,200
Closed -$923K 1446
2018
Q2
$923K Sell
3,200
-14,110
-82% -$4.07M ﹤0.01% 1235
2018
Q1
$4.33M Sell
17,310
-12,600
-42% -$3.15M ﹤0.01% 1038
2017
Q4
$7.14M Sell
29,910
-6,400
-18% -$1.53M ﹤0.01% 927
2017
Q3
$8.07M Buy
36,310
+2,800
+8% +$622K 0.01% 893
2017
Q2
$7.58M Buy
+33,510
New +$7.58M 0.01% 921